Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.

Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.

Minor histocompatibility antigens (mHA) mediate much of the graft vs. leukemia (GvL) effect and graft vs. host disease (GvHD) in patients who undergo allogeneic stem cell transplantation (SCT). Therapeutic decision making and treatments based upon mHAs will require the evaluation of multiple candida...

Full description

Bibliographic Details
Main Authors: Paul M Armistead, Shoudan Liang, Hua Li, Sijie Lu, Cornelis A M Van Bergen, Gheath Alatrash, Lisa St John, Sally A Hunsucker, Stefanie Sarantopoulos, J H Frederik Falkenburg, Jeffrey J Molldrem
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3153501?pdf=render

Internet

http://europepmc.org/articles/PMC3153501?pdf=render

Similar Items